Tomita D, Nozaki Y, Fukuda R, Morimoto Y, et al. Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study. Clin Rheumatol 2026 Sep 29. doi: 10.1007/s10067-026-08448.
PMID: 42806188